{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:24:07Z","timestamp":1789770247429,"version":"4.0.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec><jats:title>PURPOSE:<\/jats:title><jats:p>The aim of this study was to compare the effects of 0.2% polyhexamethylene biguanide (PHMB) to 0.8% metronidazole on malignant wound (MW) odor, health-related quality of life (HRQOL), and pain upon application.<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN:<\/jats:title><jats:p>A double-blinded, randomized, clinical trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>SUBJECTS AND SETTING:<\/jats:title><jats:p>Twenty-four patients with malodorous MWs hospitalized in a referral cancer center in Sao Paulo, Brazil, participated in the trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>Participants were randomly allocated to treatment with 0.8% metronidazole solution (control group) or 0.2% PHMB (experimental group). Study outcomes were measured at baseline (day 0), 4 days, and 8 days. The primary end point was the odor that was measured in terms of its intensity, quality, and impact on participants during the study period. Health-related quality of life was measured with the Ferrans and Powers Quality of Life Index\u2013Wounds Version (FPQLI-WV) on day 0 and on the day when odor was completely eliminated as per evaluation by the investigators. Pain intensity related to application of the control and experimental solutions was measured as a secondary outcome using a scale of 0 to 10.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>Twenty patients (83.3%) were classified as having \u201cno wound odor\u201d at 4 days, and 100% achieved no wound odor by day 8 (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; .001). Odor control in patients with MW significantly influenced their general HRQOL (<jats:italic toggle=\"yes\">P<\/jats:italic>= .002). We found no difference in odor elimination, or HRQOL, when patients managed with PHMB were compared to those managed with metronidazole. There were no statistically significant differences over time in pain measurement between the 2 groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>Both PHMB and metronidazole significantly reduced odor in malodorous MWs within 4 days. Neither solution was found to be more effective than the other in the magnitude of odor reduction or its effect on condition-specific HRQOL.<\/jats:p><\/jats:sec>","DOI":"10.1097\/won.0000000000000460","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T21:05:20Z","timestamp":1533675920000},"page":"413-418","source":"Crossref","is-referenced-by-count":28,"title":["Polyhexanide Versus Metronidazole for Odor Management in Malignant (Fungating) Wounds"],"prefix":"10.1097","volume":"45","author":[{"given":"Diana Lima","family":"Villela-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Lucia Concei\u00e7\u00e3o de Gouveia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"R1-20230826","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/NJH.0000000000000125","article-title":"Odor management in fungating wounds with metronidazole: a systematic review","volume":"17","author":"Castro","year":"2015","journal-title":"J Hosp Palliat Nurs"},{"issue":"24","key":"R2-20230826","first-page":"57","article-title":"Care of patients with fungating wounds","volume":"21","author":"Grocott","year":"2001","journal-title":"Nurs Stand"},{"issue":"52","key":"R3-20230826","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7748\/ns2002.09.16.52.45.c3266","article-title":"Malignant wounds: a etiology and principles of management","volume":"16","author":"Naylor","year":"2001","journal-title":"Nurs Stand"},{"issue":"1","key":"R4-20230826","first-page":"56","article-title":"Malignant cutaneous wounds: a management protocol","volume":"43","author":"Haisfield-Wolfe","year":"1997","journal-title":"Ostomy Wound Manage"},{"issue":"39","key":"R5-20230826","first-page":"81","article-title":"Fungating wounds","volume":"91","author":"Hallet","year":"1995","journal-title":"Nurs Times"},{"issue":"4","key":"R6-20230826","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejon.2009.03.008","article-title":"Malignant fungating wounds: a survey of nurses' clinical practice in Switzerland","volume":"13","author":"Probst","year":"2009","journal-title":"Eur J Oncol Nurs"},{"issue":"4)","key":"R7-20230826","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011609","article-title":"Systemic antibiotic for treating malignant wounds (protocol)","author":"Ramasubbu","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"R8-20230826","first-page":"31","article-title":"Management of a fungating wound","volume":"25","author":"Watret","year":"2011","journal-title":"J Community Nurs"},{"issue":"11","key":"R9-20230826","first-page":"12","article-title":"Fungating malignant wounds and their management","volume":"23","author":"Benbow","year":"2009","journal-title":"J Community Nurs"},{"issue":"3","key":"R10-20230826","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.soncn.2006.04.006","article-title":"Management of malignant fungating wounds in advanced cancer","volume":"22","author":"Seaman","year":"2006","journal-title":"Semin Oncol Nurs"},{"key":"R11-20230826","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2648.1990.tb01676.x","article-title":"Fungating and ulcerating malignant lesions: a review of the literature","volume":"15","author":"Ivectic","year":"1990","journal-title":"J Adv Nurs"},{"issue":"10","key":"R12-20230826","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1128\/JCM.01277-13","article-title":"Bacterial floras and biofilms of malignant wounds associated with breast cancer","volume":"51","author":"Fromantin","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"6","key":"R13-20230826","first-page":"38","article-title":"Bacterial floras and biofilms of malignant wounds associated with breast cancers","volume":"60","author":"Fromantin","year":"2014","journal-title":"Ostomy Wound Manage"},{"key":"R14-20230826","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ijnurstu.2013.10.013","article-title":"Current practice in the management of wound odour: an international survey","volume":"51","author":"Gethin","year":"2014","journal-title":"Int J Nurs Stud"},{"key":"R15-20230826","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1742-481X.2010.00715.x","article-title":"An intense and unforgettable experience: the lived experience of malignant wounds from the perspectives of patients, caregivers and nurses","volume":"7","author":"Alexander","year":"2010","journal-title":"Int Wound J"},{"issue":"6","key":"R16-20230826","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jpainsymman.2009.11.319","article-title":"A systematic review of topical treatments to control the odor of malignant fungating wounds","volume":"39","author":"Santos","year":"2010","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"R17-20230826","first-page":"1","article-title":"Wound infection in clinical practice: an international consensus","volume":"5","year":"2008","journal-title":"Int Wound J"},{"key":"R18-20230826","article-title":"Topical agents and dressing for fungating wounds","volume":"5","author":"Adderley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4\/5","key":"R19-20230826","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0959-8049(92)90142-O","article-title":"A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours","volume":"28A","author":"Bower","year":"1992","journal-title":"Eur J Cancer"},{"issue":"1","key":"R20-20230826","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/201010581402300102","article-title":"Comparing the effectiveness of green tea versus topical metronidazole powder in malodorous control of fungating malignant wounds in a controlled randomized study","volume":"23","author":"Lian","year":"2014","journal-title":"Proc Singapore Health"},{"key":"R21-20230826","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s00520-015-3067-0","article-title":"Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)","volume":"24","author":"Watanabe","year":"2016","journal-title":"Support Care Cancer"},{"issue":"3","key":"R22-20230826","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bmjspcare-2016-001166","article-title":"Improving malodour management in advanced cancer: a 10-year retrospective study of topical, oral and maintenance metronidazole","volume":"7","author":"George","year":"2017","journal-title":"BMJ Support Palliat Care"},{"key":"R23-20230826","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1469-0691.1999.tb00531.x","article-title":"Bacteroides species highly resistant to metronidazole: an emerging clinical problem","volume":"5","author":"Rotimi","year":"1999","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"R24-20230826","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/CMR.12.1.147","article-title":"Antiseptics and disinfectants: activity, action and resistance","volume":"12","author":"McDonnell","year":"1999","journal-title":"Clin Microbiol Rev"},{"issue":"suppl 1","key":"R25-20230826","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000318264","article-title":"Review on the efficacy, safety and clinical applications of polyhexanide, a modern wound antiseptic","volume":"23","author":"H\u00fcber","year":"2010","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"R26-20230826","doi-asserted-by":"crossref","first-page":"12","DOI":"10.12968\/jowc.2012.21.1.12","article-title":"Comparison of PHMB-containing dressing and silver dressing in patients with critically colonized or locally infected wounds","volume":"21","author":"Eberlein","year":"2012","journal-title":"J Wound Care"},{"issue":"2","key":"R27-20230826","first-page":"82","article-title":"Evidence summary: polyhexamethylene biguanide (PHMB) wound dressing","volume":"21","year":"2013","journal-title":"Wound Pract Res"},{"key":"R28-20230826","first-page":"45","article-title":"The effectiveness of topical polyhexamethylene biguanide (PHMB) agents for the treatment of chronic wounds: a systematic review","volume":"XXIX","author":"To","year":"2016","journal-title":"Surg Technol Int"},{"key":"R29-20230826","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1590\/S0080-62342009000500015","article-title":"Development and validation of Ferrans & Powers Quality of Life Index\u2013Wound Version","volume":"43","author":"Yamada","year":"2009","journal-title":"Rev Esc Enferm USP"},{"issue":"5","key":"R30-20230826","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1590\/S0080-623420150000500021","article-title":"Controlling wound odor with metronidazole: a systematic review","volume":"49","author":"Castro","year":"2015","journal-title":"Rev Esc Enferm USP"},{"key":"R31-20230826","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000324923","article-title":"Fungating wounds: multidimensional challenge in palliative care","volume":"6","author":"Merz","year":"2011","journal-title":"Breast Care"},{"key":"R32-20230826","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1111\/j.1365-2702.2008.02482.x","article-title":"Experiences of living with a malignant fungating wound: a qualitative study","volume":"17","author":"Lo","year":"2008","journal-title":"J Clin Nurs"},{"issue":"15","key":"R33-20230826","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.12968\/bjon.2007.16.Sup3.24528","article-title":"Psychological and physical care of malodours fungating wounds","volume":"16","author":"Lazelle-Ali","year":"2007","journal-title":"Br J Nurs"}],"container-title":["Journal of Wound, Ostomy &amp; Continence Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00152192-201809000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:52:45Z","timestamp":1720486365000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00152192-201809000-00004"}},"subtitle":["A Double-Blinded, Randomized, Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/won.0000000000000460","relation":{},"ISSN":["1071-5754"],"issn-type":[{"value":"1071-5754","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}